LeMaitre Vascular Surpasses Analyst Price Targets: What’s Next for Investors?
In recent trading, shares of LeMaitre Vascular Inc (Symbol: LMAT) have crossed above the average analyst 12-month target price of $97.25, changing hands for $99.40/share. When a stock reaches the target an analyst has set, the analyst typically has two responses: either downgrade on valuation or adjust their target price upward. Reactions from analysts may also reflect any positive developments within the company that could be driving the stock price higher.
There are eight different analyst targets within the Zacks coverage universe contributing to that average for LeMaitre Vascular Inc. However, the average is merely a mathematical mean. Some analysts have set lower price targets, with one projecting a price of $85.00, while another expects a price as high as $106.00. The standard deviation among these target prices is $6.964.
The focus on the average LMAT price target stems from the “wisdom of crowds,” an approach that gathers insights from multiple analysts rather than relying solely on a single expert opinion. With LMAT now exceeding that average target price of $97.25/share, it prompts investors to reevaluate the company’s potential. Is $97.25 merely a stopping point before reaching even higher targets, or has the valuation stretched too far, signaling the right moment to consider divesting? Below is a table detailing the current sentiments of analysts covering LeMaitre Vascular Inc:
| Recent LMAT Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
| Strong buy ratings: | 6 | 6 | 6 | 6 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 3 | 3 | 2 | 2 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.67 | 1.67 | 1.5 | 1.5 |
The average rating in the last row ranges from 1 to 5, where 1 represents a Strong Buy and 5 reflects a Strong Sell. This analysis utilized data provided by Zacks Investment Research via Quandl.com. For updated insights, access the latest Zacks research report on LMAT — FREE.
10 ETFs With Most Upside To Analyst Targets »
Also see:
• Funds Holding United Airlines Holdings
• Institutional Holders of BDCY
• Institutional Holders of WD
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
